EUVIMED · CrossrefJournal
Liver Transplantation
ISSN 1527-6465 · Ovid Technologies (Wolters Kluwer Health)
Latest articles
Validation and refinement of early allograft dysfunction criteria in living donor liver transplantation
Major Adverse Cardiovascular Events after liver transplantation: A call for a shared definition
Physiological responses to the six-minute walk test in frail/pre-frail patients with cirrhosis awaiting transplantation
Donor obesity and MASLD as barriers to living donor liver transplantation: Institutional attrition and national outcomes
Emerging applications of traditional and generative artificial intelligence in liver transplantation
Material economic hardships are associated with second-year hospitalizations after pediatric liver transplantation: Results from the SOCIAL-Tx study
Redefining early allograft dysfunction in living donor liver transplantation: Towards adaptive, graft-specific, and AI-enabled models
A case of a positive phosphatidylethanol test from blood transfusion and implications for access to clinical care
The prophylactic use of tranexamic acid in orthotopic liver transplantation: A randomized placebo-controlled study
IBAT inhibitor for refractory intrahepatic cholestasis of pregnancy in a liver-transplanted woman with Alagille syndrome
From empiricism to personalized therapy: Is there still a role for prophylactic antifibrinolytics in liver transplantation?
Letter to the Editor: From detecting sarcopenia to guiding intervention—Should bedside muscle assessment in cirrhosis be function-oriented rather than mass-oriented?
Reply: From detecting sarcopenia to guiding intervention—Should bedside muscle assessment in cirrhosis be function-oriented rather than mass-oriented?
Bridging the Hardship Gap: How can we help pediatric transplant patients and families in uncertain times
Letter to the Editor: Distinguishing pharmacological from peripheral limitation in the six-minute walk test in cirrhosis
Letter to the Editor: Does MELD 3.0’s sex correction transport to a hepatitis B/D-enriched Turkish transplant population?
Letter to the Editor: Flavin mononucleotide and hypothermic oxygenated perfusion—Prognosticating mitochondrial reconditioning
Reply: Does MELD 3.0’s sex correction transport to a hepatitis B/D-enriched Turkish transplant population?
Reply: Distinguishing pharmacological from peripheral limitation in the six-minute walk test in cirrhosis
Reply: Flavin mononucleotide and hypothermic oxygenated perfusion—Prognosticating mitochondrial reconditioning
Continuous normothermic machine perfusion is independently associated with lower risk of acute kidney injury and renal replacement therapy in donation after circulatory death liver transplantation: A propensity score matched analysis
The rejectome of acute T-cell–mediated rejection in clinical liver transplantation
Letter to the Editor: Hypothermic oxygenated machine perfusion in pediatric liver transplantation—A new platform for graft tailoring?
Reply: Hypothermic oxygenated machine perfusion in pediatric liver transplantation—A new platform for graft tailoring?
Letter to the Editor: Benchmarking a robust mitochondrial biomarker against a moving target
Reply: Benchmarking a robust mitochondrial biomarker against a moving target
2026 Reviewers (Volume 32)
Erratum: Living liver donor safety: Intraoperative considerations in living liver donation—Guidelines from the ILTS–iLDLT group consensus conference 2025
Liver perfusion sudoku: Striking a balance between organ utilization, clinical outcomes, and logistics
Living donor–domino liver transplantation for maple syrup urine disease: surgical and metabolic outcomes
EUVIMED